The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Primary Antibodies Market Research Report 2025

Global Primary Antibodies Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1888782

No of Pages : 97

Ask Your Query
Synopsis
The global Primary Antibodies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Primary Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Primary Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Primary Antibodies include Abcam, BD, Santa Cruz Biotechnology, Sigma Aldrich Corporation, Thermo Fisher Scientific, Bio-Rad, R&D Systems, MBL and CST, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Primary Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Primary Antibodies.
Report Scope
The Primary Antibodies market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Primary Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Primary Antibodies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
BD
Santa Cruz Biotechnology
Sigma Aldrich Corporation
Thermo Fisher Scientific
Bio-Rad
R&D Systems
MBL
CST
Merk
Novus Biologicals
PeproTech
Cayman
AbMax Biotechnology
MABTech
KPL
Abnova
Segment by Type
Polyclonal
Monoclonal
Segment by Application
ELISA
Western Blot
Immunostaining
Immunohistochemistry
Immunocytochemistry
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Primary Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Primary Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Primary Antibodies Market Overview
1.1 Product Overview and Scope of Primary Antibodies
1.2 Primary Antibodies Segment by Type
1.2.1 Global Primary Antibodies Market Value Comparison by Type (2024-2030)
1.2.2 Polyclonal
1.2.3 Monoclonal
1.3 Primary Antibodies Segment by Application
1.3.1 Global Primary Antibodies Market Value by Application: (2024-2030)
1.3.2 ELISA
1.3.3 Western Blot
1.3.4 Immunostaining
1.3.5 Immunohistochemistry
1.3.6 Immunocytochemistry
1.3.7 Other
1.4 Global Primary Antibodies Market Size Estimates and Forecasts
1.4.1 Global Primary Antibodies Revenue 2019-2030
1.4.2 Global Primary Antibodies Sales 2019-2030
1.4.3 Global Primary Antibodies Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Primary Antibodies Market Competition by Manufacturers
2.1 Global Primary Antibodies Sales Market Share by Manufacturers (2019-2024)
2.2 Global Primary Antibodies Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Primary Antibodies Average Price by Manufacturers (2019-2024)
2.4 Global Primary Antibodies Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Primary Antibodies, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Primary Antibodies, Product Type & Application
2.7 Primary Antibodies Market Competitive Situation and Trends
2.7.1 Primary Antibodies Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Primary Antibodies Players Market Share by Revenue
2.7.3 Global Primary Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Primary Antibodies Retrospective Market Scenario by Region
3.1 Global Primary Antibodies Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Primary Antibodies Global Primary Antibodies Sales by Region: 2019-2030
3.2.1 Global Primary Antibodies Sales by Region: 2019-2024
3.2.2 Global Primary Antibodies Sales by Region: 2025-2030
3.3 Global Primary Antibodies Global Primary Antibodies Revenue by Region: 2019-2030
3.3.1 Global Primary Antibodies Revenue by Region: 2019-2024
3.3.2 Global Primary Antibodies Revenue by Region: 2025-2030
3.4 North America Primary Antibodies Market Facts & Figures by Country
3.4.1 North America Primary Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Primary Antibodies Sales by Country (2019-2030)
3.4.3 North America Primary Antibodies Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Primary Antibodies Market Facts & Figures by Country
3.5.1 Europe Primary Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Primary Antibodies Sales by Country (2019-2030)
3.5.3 Europe Primary Antibodies Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Primary Antibodies Market Facts & Figures by Country
3.6.1 Asia Pacific Primary Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Primary Antibodies Sales by Country (2019-2030)
3.6.3 Asia Pacific Primary Antibodies Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Primary Antibodies Market Facts & Figures by Country
3.7.1 Latin America Primary Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Primary Antibodies Sales by Country (2019-2030)
3.7.3 Latin America Primary Antibodies Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Primary Antibodies Market Facts & Figures by Country
3.8.1 Middle East and Africa Primary Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Primary Antibodies Sales by Country (2019-2030)
3.8.3 Middle East and Africa Primary Antibodies Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Primary Antibodies Sales by Type (2019-2030)
4.1.1 Global Primary Antibodies Sales by Type (2019-2024)
4.1.2 Global Primary Antibodies Sales by Type (2025-2030)
4.1.3 Global Primary Antibodies Sales Market Share by Type (2019-2030)
4.2 Global Primary Antibodies Revenue by Type (2019-2030)
4.2.1 Global Primary Antibodies Revenue by Type (2019-2024)
4.2.2 Global Primary Antibodies Revenue by Type (2025-2030)
4.2.3 Global Primary Antibodies Revenue Market Share by Type (2019-2030)
4.3 Global Primary Antibodies Price by Type (2019-2030)
5 Segment by Application
5.1 Global Primary Antibodies Sales by Application (2019-2030)
5.1.1 Global Primary Antibodies Sales by Application (2019-2024)
5.1.2 Global Primary Antibodies Sales by Application (2025-2030)
5.1.3 Global Primary Antibodies Sales Market Share by Application (2019-2030)
5.2 Global Primary Antibodies Revenue by Application (2019-2030)
5.2.1 Global Primary Antibodies Revenue by Application (2019-2024)
5.2.2 Global Primary Antibodies Revenue by Application (2025-2030)
5.2.3 Global Primary Antibodies Revenue Market Share by Application (2019-2030)
5.3 Global Primary Antibodies Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abcam
6.1.1 Abcam Corporation Information
6.1.2 Abcam Description and Business Overview
6.1.3 Abcam Primary Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abcam Primary Antibodies Product Portfolio
6.1.5 Abcam Recent Developments/Updates
6.2 BD
6.2.1 BD Corporation Information
6.2.2 BD Description and Business Overview
6.2.3 BD Primary Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BD Primary Antibodies Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Santa Cruz Biotechnology
6.3.1 Santa Cruz Biotechnology Corporation Information
6.3.2 Santa Cruz Biotechnology Description and Business Overview
6.3.3 Santa Cruz Biotechnology Primary Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Santa Cruz Biotechnology Primary Antibodies Product Portfolio
6.3.5 Santa Cruz Biotechnology Recent Developments/Updates
6.4 Sigma Aldrich Corporation
6.4.1 Sigma Aldrich Corporation Corporation Information
6.4.2 Sigma Aldrich Corporation Description and Business Overview
6.4.3 Sigma Aldrich Corporation Primary Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sigma Aldrich Corporation Primary Antibodies Product Portfolio
6.4.5 Sigma Aldrich Corporation Recent Developments/Updates
6.5 Thermo Fisher Scientific
6.5.1 Thermo Fisher Scientific Corporation Information
6.5.2 Thermo Fisher Scientific Description and Business Overview
6.5.3 Thermo Fisher Scientific Primary Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Thermo Fisher Scientific Primary Antibodies Product Portfolio
6.5.5 Thermo Fisher Scientific Recent Developments/Updates
6.6 Bio-Rad
6.6.1 Bio-Rad Corporation Information
6.6.2 Bio-Rad Description and Business Overview
6.6.3 Bio-Rad Primary Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bio-Rad Primary Antibodies Product Portfolio
6.6.5 Bio-Rad Recent Developments/Updates
6.7 R&D Systems
6.6.1 R&D Systems Corporation Information
6.6.2 R&D Systems Description and Business Overview
6.6.3 R&D Systems Primary Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.4.4 R&D Systems Primary Antibodies Product Portfolio
6.7.5 R&D Systems Recent Developments/Updates
6.8 MBL
6.8.1 MBL Corporation Information
6.8.2 MBL Description and Business Overview
6.8.3 MBL Primary Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.8.4 MBL Primary Antibodies Product Portfolio
6.8.5 MBL Recent Developments/Updates
6.9 CST
6.9.1 CST Corporation Information
6.9.2 CST Description and Business Overview
6.9.3 CST Primary Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.9.4 CST Primary Antibodies Product Portfolio
6.9.5 CST Recent Developments/Updates
6.10 Merk
6.10.1 Merk Corporation Information
6.10.2 Merk Description and Business Overview
6.10.3 Merk Primary Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Merk Primary Antibodies Product Portfolio
6.10.5 Merk Recent Developments/Updates
6.11 Novus Biologicals
6.11.1 Novus Biologicals Corporation Information
6.11.2 Novus Biologicals Primary Antibodies Description and Business Overview
6.11.3 Novus Biologicals Primary Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Novus Biologicals Primary Antibodies Product Portfolio
6.11.5 Novus Biologicals Recent Developments/Updates
6.12 PeproTech
6.12.1 PeproTech Corporation Information
6.12.2 PeproTech Primary Antibodies Description and Business Overview
6.12.3 PeproTech Primary Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.12.4 PeproTech Primary Antibodies Product Portfolio
6.12.5 PeproTech Recent Developments/Updates
6.13 Cayman
6.13.1 Cayman Corporation Information
6.13.2 Cayman Primary Antibodies Description and Business Overview
6.13.3 Cayman Primary Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Cayman Primary Antibodies Product Portfolio
6.13.5 Cayman Recent Developments/Updates
6.14 AbMax Biotechnology
6.14.1 AbMax Biotechnology Corporation Information
6.14.2 AbMax Biotechnology Primary Antibodies Description and Business Overview
6.14.3 AbMax Biotechnology Primary Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.14.4 AbMax Biotechnology Primary Antibodies Product Portfolio
6.14.5 AbMax Biotechnology Recent Developments/Updates
6.15 MABTech
6.15.1 MABTech Corporation Information
6.15.2 MABTech Primary Antibodies Description and Business Overview
6.15.3 MABTech Primary Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.15.4 MABTech Primary Antibodies Product Portfolio
6.15.5 MABTech Recent Developments/Updates
6.16 KPL
6.16.1 KPL Corporation Information
6.16.2 KPL Primary Antibodies Description and Business Overview
6.16.3 KPL Primary Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.16.4 KPL Primary Antibodies Product Portfolio
6.16.5 KPL Recent Developments/Updates
6.17 Abnova
6.17.1 Abnova Corporation Information
6.17.2 Abnova Primary Antibodies Description and Business Overview
6.17.3 Abnova Primary Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Abnova Primary Antibodies Product Portfolio
6.17.5 Abnova Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Primary Antibodies Industry Chain Analysis
7.2 Primary Antibodies Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Primary Antibodies Production Mode & Process
7.4 Primary Antibodies Sales and Marketing
7.4.1 Primary Antibodies Sales Channels
7.4.2 Primary Antibodies Distributors
7.5 Primary Antibodies Customers
8 Primary Antibodies Market Dynamics
8.1 Primary Antibodies Industry Trends
8.2 Primary Antibodies Market Drivers
8.3 Primary Antibodies Market Challenges
8.4 Primary Antibodies Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock